$5.51
-1.04-15.88%
At close: -
$5.48
-0.03-0.54%
After Hours: 7:43 PM EDT
Comments
Loading...
LifeStance Health Gr Analyst Ratings and Price Targets | NASDAQ:LFST | Benzinga
LifeStance Health Group Inc has a consensus price target of $8.45 based on the ratings of 10 analysts. The high is $10 issued by Goldman Sachs on December 16, 2024. The low is $7 issued by Barclays on November 11, 2024. The 3 most-recent analyst ratings were released by Keybanc, Canaccord Genuity, and Goldman Sachs on April 8, 2025, April 3, 2025, and December 16, 2024, respectively. With an average price target of $9 between Keybanc, Canaccord Genuity, and Goldman Sachs, there's an implied 64.23% upside for LifeStance Health Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Keybanc
Canaccord Genuity
Goldman Sachs
Barclays
UBS
1calculated from analyst ratings
Analyst Ratings for LifeStance Health Gr
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/08/2025 | Buy Now | 64.23% | Keybanc | Steve Dechert 51% | → $9 | Initiates | → Overweight | Get Alert |
| 04/03/2025 | Buy Now | 45.99% | Canaccord Genuity | Richard Close46% | → $8 | Initiates | → Buy | Get Alert |
| 12/16/2024 | Buy Now | 82.48% | Goldman Sachs | Jamie Perse62% | → $10 | Upgrade | Neutral → Buy | Get Alert |
| 11/11/2024 | Buy Now | 27.74% | Barclays | Stephanie Davis41% | $6 → $7 | Maintains | Underweight | Get Alert |
| 08/15/2024 | Buy Now | 36.86% | UBS | Kevin Caliendo72% | $9 → $7.5 | Maintains | Neutral | Get Alert |
| 08/09/2024 | Buy Now | 9.49% | Barclays | Stephanie Davis41% | $8 → $6 | Maintains | Underweight | Get Alert |
| 04/22/2024 | Buy Now | 82.48% | Morgan Stanley | Ricky Goldwasser79% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 03/06/2024 | Buy Now | 64.23% | Jefferies | Brian Tanquilut45% | $8 → $9 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | 64.23% | Goldman Sachs | Jamie Perse62% | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/29/2024 | Buy Now | 45.99% | Barclays | — | $7 → $8 | Maintains | Underweight | Get Alert |
| 11/22/2023 | Buy Now | 45.99% | Goldman Sachs | Jamie Perse62% | $9 → $8 | Maintains | Neutral | Get Alert |
| 11/17/2023 | Buy Now | 45.99% | JP Morgan | Lisa Gill58% | $10 → $8 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 82.48% | JP Morgan | Lisa Gill58% | $9 → $10 | Maintains | Neutral | Get Alert |
| 07/13/2023 | Buy Now | 82.48% | Morgan Stanley | Ricky Goldwasser79% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 05/19/2023 | Buy Now | 64.23% | Goldman Sachs | Jamie Perse62% | $8 → $9 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 82.48% | Morgan Stanley | Ricky Goldwasser79% | $8 → $10 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 45.99% | Morgan Stanley | Ricky Goldwasser79% | → $8 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/15/2022 | Buy Now | 45.99% | Goldman Sachs | Jamie Perse62% | $9 → $8 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | 45.99% | Cowen & Co. | Gary Taylor59% | $10 → $8 | Maintains | Outperform | Get Alert |
| 11/07/2022 | Buy Now | — | Jefferies | Brian Tanquilut45% | — | Assumes | → Buy | Get Alert |
| 08/22/2022 | Buy Now | 82.48% | Cowen & Co. | Gary Taylor59% | $11 → $10 | Maintains | Outperform | Get Alert |
| 05/10/2022 | Buy Now | 45.99% | Morgan Stanley | Ricky Goldwasser79% | $10 → $8 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for LifeStance Health Gr (LFST) stock?
The latest price target for LifeStance Health Gr (NASDAQ:LFST) was reported by Keybanc on April 8, 2025. The analyst firm set a price target for $9.00 expecting LFST to rise to within 12 months (a possible 64.23% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LifeStance Health Gr (LFST)?
The latest analyst rating for LifeStance Health Gr (NASDAQ:LFST) was provided by Keybanc, and LifeStance Health Gr initiated their overweight rating.
When was the last upgrade for LifeStance Health Gr (LFST)?
The last upgrade for LifeStance Health Group Inc happened on December 16, 2024 when Goldman Sachs raised their price target to $10. Goldman Sachs previously had a neutral for LifeStance Health Group Inc.
When was the last downgrade for LifeStance Health Gr (LFST)?
There is no last downgrade for LifeStance Health Gr.
When is the next analyst rating going to be posted or updated for LifeStance Health Gr (LFST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeStance Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeStance Health Gr was filed on April 8, 2025 so you should expect the next rating to be made available sometime around April 8, 2026.
Is the Analyst Rating LifeStance Health Gr (LFST) correct?
While ratings are subjective and will change, the latest LifeStance Health Gr (LFST) rating was a initiated with a price target of $0.00 to $9.00. The current price LifeStance Health Gr (LFST) is trading at is $5.48, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
